Trial Profile
Cardiac safety of continuous trastuzumab in breast cancer patients with asymptomatic left ventricular dysfunction: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2016
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 03 Aug 2016 New trial record